A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is ...

Please provide your email address to receive an email when new articles are posted on . Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to ...

Key Takeaways A new drug combo can help maintain long-acting control over HIVHIV can develop resistance to rilpivirine, one of the two drugs in a commonly prescribed long-term injectionSwapping ...

A new iScience study shows that combining a selective CDK9 inhibitor with a PP2A-activating drug durably silences HIV ...

Learn how people with HIV can protect heart and bone health while on ART, including screening guidelines, lifestyle tips, and ...

Descovy (emtricitabine/tenofovir alafenamide) is a brand-name tablet prescribed for treating HIV. Descovy works by blocking HIV from multiplying and spreading in the body. Nausea was the more common ...

A difference-in-differences study found that removing South Carolina's Medicaid prescription cap increased antiretroviral ...

In a report on the so-called REMEMBER (Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment) study—a 10-nation, randomized clinical trial of adult outpatients—investigators ...

Individuals with HIV have a higher prevalence of MASLD and dyslipidemia compared to controls, but are not more metabolically ill overall. The study used a case-control design with 60 HIV-positive ...

On National Latinx AIDS Awareness Day, experts outline HIV prevention gaps in Hispanic communities and how payers can ease ...